This study focuses on children with acute myocarditis, which is a condition where the heart muscle becomes inflamed. The research evaluates the effectiveness of a medication called Anakinra compared to placebo, given along with standard medical care. The purpose is to see if this treatment can help restore normal heart function in children who are being treated in intensive care units.
The medication Anakinra is given through subcutaneous injection (an injection under the skin) for 7 days. The treatment involves daily doses of 100 mg of the medication. Some patients will receive sodium chloride solution as a placebo treatment instead of the active medication.
The study monitors how well the heart functions after starting the treatment, particularly focusing on the heart’s ability to pump blood effectively. The research team will track the children’s progress for up to 6 months after treatment begins, checking their heart function and watching for any side effects that might occur during the treatment period.
France 